skip to content
skip to main navigation
skip to section navigation

You are here:

Policy Statements

A Guide to Quality Adjusted Life Years

Consistent SMC and SIGN Advice on New Medicines for NHSScotland (PDF)

Declarations of Interest

Post-Code Prescribing

CEL 17 (2010) The Introduction and Availability of Medicines in the NHS in Scotland

New medicines in Scotland - who decides what the NHS can provide

Meetings with Manufacturers

Process for a Resubmission/Independent Review Panel (IRP)

SMC process for issuing ‘not recommended’ advice due to non-submission by a pharmaceutical company

Biosimilar Medicines

Release of Economic Checklist to Industry

Release of Company Data

Definitions for Generic Products